posted
If you have the ability to look at a 3 - 5 day intraday chart with 15 min. intervals. It looks like LBTT has been gaining ground since about 11:00 on the 30th. Slow and steady.
I am lloking for it to break .03 by about 1:00 today if it keeps the same pace.
PAUL
------------------ But godliness with contentment is great gain. For we brought nothing into this world, and it is certain we can carry nothing out.
posted
GEEEEZ! Lighten up Paul, I was teasing ya man. Got to have a little fun with this crap too.
quote:Originally posted by PAUL: Will,
I chose as examples, stock I have held. Trying not to get into a discussion like this. Oh well.
I choose not to detatch causes from profits as you put it. There are just some things I would rather not invest in. I am sure it is that way with everyone, we just all draw our lines in the sand at different places fro different reasons.
I hope this post and my previous post did not seem like I was trying to keep people from investing in something they want to invest in. It was not my intention. Again this is whay I pick stock I have held or am holding.
My post was intended to be more so about the good LBTT might be able to do, not the bad that other companies are doing.
Sorry if I was not clear. Not trying to put anyone or any company down.
PAUL
Posts: 4893 | From: Burbank IL USA | Registered: Feb 2004
| IP: Logged |
posted
Lifeline's founder Dr. Reeves says we can expect positive PR regarding favorable results of our recent conferences and conventions, product sales projections, and the status of our recent funding efforts.
Posts: 10 | Registered: Dec 2003
| IP: Logged |
posted
Hi Paul, You were only off by 3 hours for the .03. Most Pros would be pleased!!! Good job. I do think this will go up in the long run. Of course I want it to go up sooner. I hate to see capital tied up looking all stagnant. When it finally announces some big news and runs it should be sweet. IMO-DD-GLTA-Debi
Posts: 1188 | From: Clinton, MA 01510 | Registered: Jan 2004
| IP: Logged |
posted
that buy for 1 million @ .03 went thru at 3:56 I believe, If this one flys it will be my first big break in the stock market. all we need is a good sales report from the shows, and a fincial filling would also be nice. Good luck to everyone.
Posts: 7 | Registered: Mar 2004
| IP: Logged |
posted
If the trend I was watching was going to continue, I was expecting it to trade HIGHER than .03 by my statd time.
Oh well, it was fun to watch.
Long & Strong
PAUL
quote:Originally posted by WWJD-thru-me: Hi Paul, You were only off by 3 hours for the .03. Most Pros would be pleased!!! Good job. I do think this will go up in the long run. Of course I want it to go up sooner. I hate to see capital tied up looking all stagnant. When it finally announces some big news and runs it should be sweet. IMO-DD-GLTA-Debi
------------------ But godliness with contentment is great gain. For we brought nothing into this world, and it is certain we can carry nothing out.
This has been trading at.03 for 3 days if you look at the charts, its not just touching.
It has traded at .03 since beginning of Feb although it hit that high quickly once or twice. I wouldn't count it out with the Vegas convention going on right now.
Techs aren't looking great but not looking bad either.
Keith
Posts: 9110 | From: boston, ma | Registered: Jan 2004
| IP: Logged |
posted
LBTT has been trading low in response to the whole maket being low the last three weeks. Now with the New jobs beig reported all economic news is Bullish and alot of better stocks will raise to their former highs as the anticipation for Pr gets closer. LBTT is Pee Owed at the MM's and may release a PR just to put in their face now april 1st has past. Just observation and wishful thinking. and Fishstix should have PAVP running for ya this week Dave
Posts: 1068 | From: Utah and Put-In-Bay Ohio | Registered: Jan 2004
| IP: Logged |
posted
I think what I was watching was an intraday chart at 15 min. Watching it from TUESDAY of last week. Wow. I was watching how it was moving, slow but consistant. That was what I was seeing should break .03 by 1 pm Thursday.
(edited version)
I think this one will do great long term. I consider this one to be my strongest hold right now. This from a guy who does not prefer pink sheet stock. (holding LBTT & CMKX)
Hope this is a good week in the market.
PAUL
------------------ But godliness with contentment is great gain. For we brought nothing into this world, and it is certain we can carry nothing out.
[This message has been edited by PAUL (edited April 05, 2004).]
Press Release Source: Lifeline Biotechnologies, Inc.
Lifeline Biotechnologies Introduces Its MastaScope at Major European Breast Cancer Conference Monday April 5, 9:05 am ET
HAMBURG, Germany--(BUSINESS WIRE)--April 5, 2004--Jim Holmes Lifeline Biotechnologies' (OTC:LBTT - News) CEO, today announced the successful introduction of the Company's first internally developed product, the MastaScope(TM) (formerly referred to as the Nipplescope) at the 4th Annual European Breast Cancer Conference recently concluded. Professor Kefah Mokbel (London, UK), the lead investigator who directed Lifeline's development of the MastaScope noted that "industry delegates and medical professionals who visited Lifeline's booth at this well attended conference were highly impressed by the compact nature and clear images the system is capable of displaying."
Dr. Louis Keith, Lifeline Medical Director said, "Numerous visitors were enthusiastic and indicated positive impressions. The MastaScope, which has been under development by Lifeline over the last year and a half, is used for Mammary Ductoscopy -- Visualization of Breast Abnormalities for Patients with Nipple Discharge."
Dr. William Reeves, Lifeline's President and founder, said he was "overwhelmed by the response and interest this conference has generated in the MastaScope."
Carlo Micheletti, Lifeline's Director of International Sales and Marketing noted that representatives from the United Kingdom, Italy, Germany, The Netherlands, Croatia, Sweden, Finland, Russian Federation. Lebanon, Turkey, Iran, Thailand, Egypt, Libya, Brazil, Argentina and Belgium have indicated an interest in acquiring the MastaScope. Mr. Micheletti indicated that sales orders are expected to be received from these sources and that many of these interested parties are potential distributors for MastaScope in their respective geographies.
The European Breast Cancer Conference is coordinated by the Federation of European Cancer Societies (www.fecs.be).
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, when used in the preceding discussion, the words "believe," "expects," "projects," "forecasts," "intends," "will," "anticipated," "could," or "may," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the act and subject to the safe harbor created by the act. Except for historical information, all of the statements contained in the foregoing are forward-looking statements that involve a number of risks and uncertainties.
-------------------------------------------------------------------------------- Contact: Lifeline Biotechnologies, Inc. Jim Holmes, 775-324-1933 jholmes@lbti.com or Stock Enterprises Jim Stock, 866-242-2405 (Investor Relations) stockenter@aol.com
-------------------------------------------------------------------------------- Source: Lifeline Biotechnologies, Inc.
Email this story - Set a News Alert
[This message has been edited by keithsan (edited April 05, 2004).]
Posts: 9110 | From: boston, ma | Registered: Jan 2004
| IP: Logged |
posted
Showing interest isn't HARD ORDERS. I think the PR was soft. If they said we booked x amount of orders, differnt story then.
Posts: 4893 | From: Burbank IL USA | Registered: Feb 2004
| IP: Logged |
posted
Agreed. Everyone expected interest thats why they bought. Now we need to know whos buying! Maybe after Vegas. I was glad it didn't drop on the PR. Technically friday closed at .03 but last sale over the ask. Traded at .028/.029 all day. Similar day on Monday!
Keith
quote:Originally posted by will: Showing interest isn't HARD ORDERS. I think the PR was soft. If they said we booked x amount of orders, differnt story then.
Posts: 9110 | From: boston, ma | Registered: Jan 2004
| IP: Logged |
posted
I was expecting more from that PR. I will hold this one till May 1 and if the PPS does not explode to .10 by then I am out.
Posts: 7 | Registered: Mar 2004
| IP: Logged |
posted
I would have prefered to have them sell many units there but, I think what happened is probably normal.
I think that what they are leaving the conference with is a great list of "HOT LEADS". They have also been able to show people in the industry that they can have a more clear picture than was available to them before.
Hopefully many of those that were interestd in the MastaScope at the conference, left the conference excited about the MastaScope.
If the introduction took place at the conference. I think the "selling" begins NOW. Following up on those "hot leads". Those people that were at the conference are now back at work. Dealing with people that need help. (If in management, at least dealing with the people, that deal with the people.)If only they had the MastaScope, they could provide a less invasive proceedure that would result in an accurate diagnosis.
BTW..
Does anyone know how much their MastaScope cost? How large is it? How much does it weigh?
PAUL
------------------ But godliness with contentment is great gain. For we brought nothing into this world, and it is certain we can carry nothing out.
[This message has been edited by PAUL (edited April 06, 2004).]
quote:Originally posted by fishstix12345: I was expecting more from that PR. I will hold this one till May 1 and if the PPS does not explode to .10 by then I am out.
------------------ But godliness with contentment is great gain. For we brought nothing into this world, and it is certain we can carry nothing out.
posted
I can't answer the cost question. I am pondering the interest versus sales PR. I don't know what kind of additional training you would want or need to use this device. It is possible that people are interested but need to look into that kind of question. Who is going to use it and how is the practitioner going to develop their ability to be comfortable with this procedure? More and more patients are encouraged to stay awake during procedures. A needle in the nipple doesn't sound pleasant and I wouldn't want to be a guinea pig. But it is needed and will be used but I think these will be sold by LBTT's staff to Doctor's and offices on the list of interested health professionals. Sold is the key word, they will close the deals by answering questions, addressing concerns and taking the needed time to do it. IMO-Debi
Posts: 1188 | From: Clinton, MA 01510 | Registered: Jan 2004
| IP: Logged |
posted
Interest is a good thing, and probably what can be expected from a show. As far as sales are concerned, sounds as if they are looking for distributors in the interested countries, as opposed to selling direct to Hospitals and/or Drs there.
Posts: 4893 | From: Burbank IL USA | Registered: Feb 2004
| IP: Logged |
posted
Will, It does sound like the want distributors also. Honestly before the PR, I had never considered distributors. I was also excited about that. Gaining 10 distributors would be better than making ten sells. (If you know the product has a market)
PAUL
quote:Originally posted by will: Interest is a good thing, and probably what can be expected from a show. As far as sales are concerned, sounds as if they are looking for distributors in the interested countries, as opposed to selling direct to Hospitals and/or Drs there.
------------------ But godliness with contentment is great gain. For we brought nothing into this world, and it is certain we can carry nothing out.
Jim Holmes Lifeline Biotechnologies'(OTC:LBTT) CEO, today announced the successful introduction of the Company's first internally developed product, the MastaScope(TM) (formerly referred to as the Nipplescope) at the 4th Annual European Breast Cancer Conference recently concluded.
Professor Kefah Mokbel (London, UK), the lead investigator who directed Lifeline's development of the MastaScope noted that 'industry delegates and medical professionals who visited Lifeline's booth at this well attended conference were highly impressed by the compact nature and clear images the system is capable of displaying.'
Dr. Louis Keith, Lifeline Medical Director said, 'Numerous visitors were enthusiastic and indicated positive impressions. The MastaScope, which has been under development by Lifeline over the last year and a half, is used for Mammary Ductoscopy -- Visualization of Breast Abnormalities for Patients with Nipple Discharge.'
Dr. William Reeves, Lifeline's President and founder, said he was 'overwhelmed by the response and interest this conference has generated in the MastaScope.'
Carlo Micheletti, Lifeline's Director of International Sales and Marketing noted that representatives from the United Kingdom, Italy, Germany, The Netherlands, Croatia, Sweden, Finland, Russian Federation. Lebanon, Turkey, Iran, Thailand, Egypt, Libya, Brazil, Argentina and Belgium have indicated an interest in acquiring the MastaScope.
Mr. Micheletti indicated that sales orders are expected to be received from these sources and that many of these interested parties are potential distributors for MastaScope in their respective geographies.
Posts: 164 | From: greenville, SC, USA | Registered: Mar 2004
| IP: Logged |
posted
Paul, good post you wrote at 9:04 this morning. Everything you said is what I also believe. People who were at the conference have to bring the info back to their countries and look it over before they put in orders. Believe me there will be orders! Anything that can detect breast cancer 10 yrs. before a Mammogram can show it will be a mega hit in the medical community. The cost of the scope is around $6,000 and it's hand held. Go to their website (www.lbti.com) and see the photo of what it looks like. Acueity's scope is more expensive and the images are not as clear as LBTT. Another plus with this scope is that it's so small every drs. office can have one. The Mammogram is so big that only clinics and hospitals have them and the cost is over 1/2 mil. & up. The scope itself is the size of the lead in a pencil. This procedure will be done right in the drs. office and the women will go home right after the exam. This scope has already been in trials for over a year now. I think somewhere in South America. Imo this is a long term hold and the people who hold for the long term will be well rewarded. So won't the millions of women's live this co. will save. The bread and butter of this co. will be the First Warning System (FWS). They are correcting the false positives right now. They have 3 engineering firms working on this problem. Phase III trials will be in Austria which could already be starting. Don't forget they're still working on their OvaScope for detection of Ovarian cancer. They also have a picture of this scope on their website. GLTA
posted
if they have 3 engineering companies working on the false positives, it sounds like a pretty big problem. could this not deter people from buying the product?
Posts: 353 | From: Bay Area, CA | Registered: Feb 2004
| IP: Logged |
LAS VEGAS, Apr 7, 2004 (BUSINESS WIRE) -- Jim Holmes, CEO, Lifeline Biotechnologies (OTC: LBTT) today announced the U.S. introduction of the company's Mastascope(TM) at the recent annual conference of the American Society of Breast Surgeons. Holmes noted, "This conference, for its size and influence, was as rewarding as our successful introduction of the Mastascope(TM) in Europe, two weeks ago."
Jonathan Reeves, Lifeline's vice president, who managed the company's product booth at the conference noted, "The first U.S. sale has been completed, payment received and the Mastascope(TM) system shipped. We will be actively following up on the numerous high-quality sales leads we've received, many of whom have requested hospital demonstrations. This introduction is our national kickoff of our rollout program. We are in the process of training our distributors and provided them with the materials and support needed to place this product with the target users and increase sales."
Dr. William Reeves, Lifeline's president and founder, commented, "This was a great opportunity for professor Louis Keith, our medical director and me to interface with some of the country's leading breast cancer authorities. The Mastascope(TM) technology was very well received by all the physicians who attended our booth, many of whom commented, 'The technology has finally caught up with the concept.'" Reeves commented further, "The Mastascope(TM) introduction, as a new concept, in early breast cancer detection will act as a forerunner to the First Warning(TM) Breast Monitor. In addition, the introduction of the Mastascope(TM) provided an excellent opportunity for management to discuss the underlying medical concepts that will be new to breast cancer detection, with some of the country's leading academics, who help form as well as influence medical opinion."
Reeves went on to comment, "Because of professor Keith's long-standing reputation and influence as a teacher and medical educator, Lifeline's opportunities to interface with medical professionals exists, who would otherwise be inaccessible to our company. Dr. Keith has opened doors for us that will be very helpful in development of this product in the market and the utilization of the Mastascope(TM) by physicians."
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, when used in the preceding discussion, the words "believe," "expects," "projects," "forecasts," "intends," "will," "anticipated," "could," or "may," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the act and subject to the safe harbor created by the act. Except for historical information, all of the statements contained in the foregoing are forward-looking statements that involve a number of risks and uncertainties.
SOURCE: Lifeline Biotechnologies
Lifeline Biotechnologies Inc. Jim Holmes, 775-324-1933 jholmes@lbti.com or Stock Enterprises Investor Relations Jim Stock, 866-242-2405 stockenter@aol.com
posted
this is just the first good news in a series of good news to be released as stated in the previous PR
Posts: 59 | Registered: Dec 2003
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
